Fact CheckerSign in

NCT07002697Recruiting

Geometrical Influences on Atherosclerosis and Blood Flow

High-Risk Plaques Identification Using Coronary Computed Tomography and Computational Fluid Dynamics

Source: ClinicalTrials.gov · Last updated 3 Jun 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The study investigates the use of advanced imaging techniques and computational methods to identify high-risk plaques in coronary arteries. These plaques are significant because they have the potential to cause acute coronary syndrome (ACS), a condition that includes heart attacks and unstable angina. The research focuses on integrating Coronary Computed Tomography (CCT) with Computational Fluid Dynamics (CFD) to provide detailed insights into plaque characteristics and their hemodynamic environment. The study's primary aim is to enhance the early detection and characterization of high-risk coronary plaques that could lead to ACS. By combining CCT, a non-invasive imaging technique, with CFD, which stimulates blood flow dynamics, the study seeks to: Identify High-Risk Plaques, Apply CFD to analyze the blood flow around these plaques, Improve Prediction of ACS, Inform Clinical Decision-Making. Computational fluid dynamics (CFD) analysis of CCT data can also provide a non-invasive hemodynamic assessment to identify high-risk plaques destined to cause acute coronary syndrome. Patients with adverse plaque characteristics like positive remodeling or low-attenuation plaque have a greater risk of future coronary events.

Status (registry)
Recruiting
Study type
Observational
Enrollment
30 (estimated)
First submitted
19 Apr 2025
Start date
10 Aug 2024
Primary completion date
11 Oct 2025
Lead sponsor
Bangladesh University of Engineering and Technology
NCT number
NCT07002697

What you commit to

  • Study type: Observational
  • Planned participants: 30
  • From 10 Aug 2024 to the primary completion date, 11 Oct 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous allergic reaction to iodinated contrast media.

Other illness

  • Severe renal impairment (due to contrast media risk).

Other

  • Pregnant or lactating women.

Who the study is looking for

  • Adults aged 40-70 years.
  • Presenting with symptoms of CAD (e.g., chest pain, shortness of breath) or having multiple risk factors (e.g., hypertension, diabetes, smoking).
  • Able to provide informed consent.

Age in the registry: 40 years to 70 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
National Institute of Cardiovascular Disease (NICVD)
Coordinator of this site? Confirm its status
DhakaBangladeshRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.